Comcast deploys $1M in Houston to shrink digital divide

access for all

This tech giant is extending access to the internet for those who need it. Photo courtesy of Comcast

Global Internet service provider, Comcast, is investing more than $1 million locally to help give families in the Houston region an opportunity to thrive in the digital age.

The funds are aimed to help students, adults and people with disabilities to ‘level up’ their computer, career development and tech education skills. The million-dollar investment will also support ongoing efforts to build awareness about low-cost or no-cost connectivity programs like Internet Essentials and the federal government’s Affordable Connectivity Program.

“The Internet is where life happens. It allows students to expand their educational aspirations and it empowers parents to explore better job openings so they can ultimately deliver a better quality of life for their families,” says Ralph Martinez, Comcast Houston’s regional senior vice president. “We are passionate about doing our part to close the digital divide and committed to helping establish a more equitable foundation for learning, working and succeeding.”

This effort is part of the company’s $1 billion, decade-long commitment to expand access to the internet across the world and open doors for the next generation of innovators, entrepreneurs, storytellers and creators.

In December 2021, Comcast donated funds to support local diversity-focused non-profit, SERJobs. 

So far, Comcast has given grants to eight Houston area organizations. More announcements will be made later this year, according to the company’s press release.

  • United Way | Funding will be used to provide tech experts (Digital Navigators) to help people in need of digital skills training.
  • BakerRipley | Funding will support computer skills, software, email and internet safety training for low-income adults in the Houston area.
  • Comp-U-Dopt | Funding will support students participating in Early Adopters, STEAM Team and Learn2Earn, which brings technology education to area youth. Comp-U-Dopt will also use the funding to provide tech experts (Digital Navigators) to help people in need of digital skills training.
  • Easter Seals of Greater Houston | Funding will support the development of a curriculum for people with disabilities to help them successfully learn to use digital technology to gain and maintain employment
  • The Boys and Girls Club of Greater Houston | Funding will help high school students gain technical and leadership skills through the Workforce Readiness Program.
  • AAMA | Funding will be used to purchase technology and equipment to support students through the training program at the Work and Learn Center, with an emphasis on digital literacy and design.
  • Dress for Success | Funding will be used to provide Houston-area women with the resources needed to obtain long-term employment through access to job readiness training, digital skills workshops, computers and mobile labs.
  • AVANCE-Houston | Funding will support adult literacy program and continue to build pathways to economic mobility for families in the community.
Nancy and Rich Kinder have donated $1 million to the United Way. Photo by Michelle Watson/Catchlight Group

Houston's billionaire benefactors gift another $1 million to citywide charity

a united front

Arguably Houston’s most recognizable benefactors, Rich and Nancy Kinder have done it again. The billionaire couple, known for mammoth donations throughout the city, have just donated $1 million to the United Way of Greater Houston, the organization announced.

According to the United Way, the Kinders’ gift addresses the impact of the pandemic on the local economy, and how it has raised unemployment, drained household finances, and strained nonprofit basic needs resources.

“Lifting up the many hard-working families and individuals in our community and supporting their pathway to self-sufficiency is an effective and critically important approach,” said Nancy Kinder, president and CEO of the Kinder Foundation. “We support United Way of Greater Houston’s new strategic vision because we recognize the impact it can have on those seeking a sustainable quality of life.”

As CultureMap has previously reported, the Kinders are longtime donors to the United Way; this is the third consecutive year the couple has made a $1 million campaign gift at the nonprofit’s Luminary Leadership Giving level.

That Luminary Leadership Giving level is the highest within United Way of Greater Houston’s Alexis de Tocqueville Society, which is a group of generous individuals currently numbering more than 700. The group is noted for making gifts of $10,000 or more annually to United Way of Greater Houston. The group contributed more than $17 million to United Way last year, per a press release.

This year, the Kinders landed on the annual Forbes list of the wealthiest Americans. Houstonians will no doubt recognize the couple from other hefty local allotments, including the game-changing, $70 million donation to Memorial Park.

They are also behind the stunning and newly opened Nancy and Rich Kinder Building at the Museum of Fine Arts, Houston.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings